Breast carcinoma: Epidemiology and risk factors;Mammakarzinom: Epidemiologie und risikofaktoren

Journal fur Gastroenterologische und Hepatologische Erkrankungen

Volumn 9, Issue 2, 2011, Pages

  Kunze, Ursula ^a  

^a Medical University of Vienna and Wiener Werkstaette for Suicide Research   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; REVIEW; RISK FACTOR;

EID: 79960030229     PISSN: 17286263     EISSN: 17286271     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Ferlay J, Bray F, Pisani P, et al. Globocan 2003. Cancer Incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, Version 2.0. IARC Press, Lyon, 2004.
2. Braendle W, Kuhl H, Mueck AO, et al. Erhöht die hormonale Kontrazeption das Tumorrisiko? Therapeutische Umschau 2009; 2: 129-35.
3. Coleman MP, Quaresma M, Berrino F, et al.; CONCORD Working Group. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-56.
4. Curado MP, Edwards B, Shin HR, et al. (eds). Cancer incidence in five continents. Scientific Publications # 160. IARC, Lyon, 2007.
5. Cuzick J. Hormone replacement therapy and the risk of breast cancer. Eur J Cancer 2008; 44: 2344-9.
6. Dey S, Soliman A, Merajver S. Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Med Hypotheses 2009; 72: 652-6.
7. Dunitrescu RG, Cotarla I. Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 2005; 1: 208-21.
8. Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet 2001; 398: 56-63. (Pubitemid 32709745)
9. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92.
10. Han D, Freudenheim JL, Nie J, et al. Geographic differences in breast cancer cases and controls by genetic and biological characteristics: explaining clustering of breast cancer at place of birth. Proc Amer Assoc Cancer Res 2005; 46: # 3214.
11. Harlap S, Olson S, Akhmedkhanov A, et al. Epithelial ovarian carcinoma and European birthplace of grandparents. Gynecol Oncol 2001; 81: 25-32. (Pubitemid 32368073)
12. Kuhl H. Epidemiologie, Mammakarzinom und Hormonersatztherapie. J Menopause 2003; 10: 5-9.
13. Levi F, Bosetti C, Lucchini F, et al. Monitoring the decrease in breast cancer in Europe. Eur J Cancer Prev 2005; 14: 497-502. (Pubitemid 41689648)
14. Lof M, Weiderpass E. Impact of diet on breast cancer risk. Curr Opin Obstet Gynecol 2009; 21: 80-5.
15. Luzuy F. Hormonersatztherapie und Brustkrebsrisiko: aktuelle Situation. J Menopause 2005; 12: 22-4. (Pubitemid 40790704)
16. Mackenbach JP, Stirbu I, Roskam AJ, et al. Socio-economic inequalities in health in 22 European countries. N Engl J Med 2008; 208: 2468-81. (Pubitemid 351793020)
17. Michels KB, Mohllajee AP, Roset-Bahmanyar E, et al. Diet and breast cancer: a review of the prospective observational studies. Cancer 2007; 109 (Suppl): 2712-49. (Pubitemid 46906454)
18. Millen AE, Pettinger M, Frudenheim JL. Incidence invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev 2009; 18: 495-507.
19. Mishra GD, Cooper R, Tom SE, et al. Early life circumstances and their impact on menarche and menopause. Womens Health 2009; 5: 175-90.
20. Parkin DM. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 2009; 45: 1649-53.
21. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. New Engl J Med 2008; 358: 213-6.
22. Reeves GK, Pirie K, Green J, et al.; Million Women Study Collaborators. Reproductive factors and specific histological types of breast cancer: productive study and meta-analysis. Br J Cancer 2009; 100: 538-44.
23. Sant M, Allemani C, Santaquilani M, et al. The Eurocare Working Group: Eurocare 4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-91.
24. Sieri S, Krogh V, Ferrari P, et al. Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2008; 88: 1304-12.
25. Strand BH, Kunst A, Huisman M, et al.; EU Working Group on Socioeconomic Inequalities in Health. EU Working Group on Socioeconomic Inequalities in Health: The reversed social gradient: higher breast cancer mortality in the higher educated compared to lower educated. A comparison of 11 European populations during the 1990s. Eur J Cancer 2007; 43: 1200-7. (Pubitemid 46613957)
26. Strand BH, Tverdal A, Claussen B, et al. Is birth history the key to highly educated women's higher breast cancer mortality? A follow u study of 500.000 women aged 35-54. Int J Cancer 2005; 117: 1002-6. (Pubitemid 41688577)
27. Sundquist J. The relevance of birthplace. National Institute of Public Health, Sweden, 2004.
28. Vutuc C, Waldhoer T, Haidinger G. Cancer mortality in Austria: 1970-2002. Wien Klin Wochenschr 2004; 116: 669-75.
29. Yang L, Jacobsen KH. A systematic review of the association between breastfeeding and breast cancer. J Women's Health 2008; 10: 1635-45.